EUROPEAN BIOTECH ACQUTN CORP's ticker is EBAC and the CUSIP is G3167F102. A total of 47 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $353,480 | +1.9% | 34,998 | 0.0% | 0.01% | 0.0% |
Q3 2022 | $347,000 | +1.5% | 34,998 | 0.0% | 0.01% | +20.0% |
Q2 2022 | $342,000 | 0.0% | 34,998 | 0.0% | 0.01% | +25.0% |
Q1 2022 | $342,000 | +0.9% | 34,998 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $339,000 | -0.3% | 34,998 | 0.0% | 0.00% | -20.0% |
Q3 2021 | $340,000 | – | 34,998 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Exos Asset Management LLC | 45,300 | $441,000 | 0.23% |
MMCAP International Inc. SPC | 250,000 | $2,435,000 | 0.12% |
Atalaya Capital Management LP | 40,000 | $386,000 | 0.10% |
Radcliffe Capital Management, L.P. | 200,000 | $1,942,000 | 0.06% |
Arena Capital Advisors, LLC- CA | 75,000 | $731,000 | 0.06% |
FIR TREE CAPITAL MANAGEMENT LP | 150,000 | $1,449,000 | 0.05% |
Athanor Capital, LP | 147,800 | $1,428,000 | 0.05% |
Woodline Partners LP | 275,000 | $2,654,000 | 0.05% |
Ghisallo Capital Management LLC | 125,000 | $1,208,000 | 0.05% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 300,000 | $2,922,000 | 0.04% |